1 – 10 of 35
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
An oat bran-based beverage reduce postprandial glycaemia equivalent to yoghurt in healthy overweight subjects.
(
- Contribution to journal › Article
- 2013
-
Mark
Oral administration of live exopolysaccharide-producing Pediococcus parvulus, but not purified exopolysaccharide suppressed Enterobacteriaceae without affecting bacterial diversity in caecum of mice.
(
- Contribution to journal › Article
- 2012
-
Mark
Effects of Pediococcus parvulus 2.6 and its exopolysaccharide on plasma cholesterol levels and inflammatory markers in mice
(
- Contribution to journal › Article
-
Mark
Evaluation of commercial microbial hydrocolloids concerning their effects on plasma lipids and caecal formation of SCFA in mice
(
- Contribution to journal › Article
- 2011
-
Mark
Simultaneous intake of oat bran and atorvastatin reduces their efficacy to lower lipid levels and atherosclerosis in LDLr-/- mice
(
- Contribution to journal › Article
- 2010
-
Mark
Oats (Avena sativa) reduce atherogenesis in LDL-receptor-deficient mice.
(
- Contribution to journal › Article
-
Mark
Effects of oats on plasma cholesterol and lipoproteins in C57BL/6 mice are substrain specific.
(
- Contribution to journal › Article
-
Mark
Effects of oat bran, processed to different molecular weights of beta-glucan, on plasma lipids and caecal formation of SCFA in mice.
(
- Contribution to journal › Article
-
Mark
Characterization of the properties of Pediococcus parvulus for probiotic or protective culture use.
(
- Contribution to journal › Article
- 2009
-
Mark
Extraction of beta-Glucan from Oat Bran in Laboratory Scale
(
- Contribution to journal › Article